Catalog  |  Cart  |  Log In

 

Application and Utilization of STR Multiplexes for Parentage Analysis

Steve D. Creacy, Charles M. Kelly and Robert A. Bever
Genetic Design, Inc., 7017 Albert Pick Road, Greensboro, NC


MATERIALS AND METHODS
Isolation of Genomic DNA
Amplification Conditions
Detection of Amplified Products
RESULTS AND DISCUSSION
ACKNOWLEDGMENTS
REFERENCES
TABLES and FIGURES

The human genome contains hundreds of loci which contain tetrameric repeats of varying lengths (1,2). These short tandem repeat loci (STR) have been utilized for use in forensic and paternity case work (3,4). Last year we reported on the validation of five of the STR loci (CSF1PO, TPOX, TH01, vWA [formerly vWFA31], and FESFPS) for the use in paternity casework (5).

This report describes the validation of three more loci: F13A01, F13B, and LPL (6,7,8). The systems were validated by determining the frequencies of heterozygotes in the population, allelic frequencies, and observed powers of exclusion for each of the loci.

MATERIALS AND METHODS

Two hundred exclusionary paternity cases of each racial group were used for determining the allele frequencies, heterozygosity values and powers of exclusion for the three STR loci. The allele frequencies were determined by analyzing the mothers and alleged fathers of these exclusionary cases. These exclusionary cases were previously analyzed by RFLP analysis using the loci D10S28, D2S44, D4S139, D17S26 and D1S339.

Isolation of Genomic DNA

DNA was isolated from whole blood using a modified non-organic extraction technique (9) and from buccal cells by phenol chloroform isolation (5). DNA was quantitated by a standard fluorescent technique (10) using a microplate fluorometer (Cambridge Technology, Inc.).

Amplification Conditions

Amplification for loci F13A01, F13B, and LPL was completed with reagents and protocols provided by Promega Corporation's GenePrint™ STR Kit DC6000 and DC6010. These procedures are described in the STR Systems GenePrint™ Technical Manual (Promega Corporation, Madison, WI). However, the procedures were slightly modified for use with the Biotherm III BioOven.

A master mix containing the STR multiplex primers, 10X STR buffer, sterile water, and Taq DNA Polymerase (.01 units/ml, Perkin Elmer) is mixed with genomic DNA on ice or a cold block. The final reaction volume is 25 µl containing 10-50ng of DNA. DNA was amplified in a Biotherm III BioOven. Typical amplification conditions for the multiplex (F13A01, F13B, and LPL) consisted of a hot soak at 95ºC for 3 minutes, 30 cycles of 94ºC for 1 minute, 60ºC 1 minute and 70ºC for 1.5 minutes, followed by a final extension at 72ºC for 5 minutes. Positive control K562 DNA and a negative control were run on each batch of amplified DNA.

Detection of Amplified Products

Amplified DNA product was separated by polyacrylamide gel electrophoresis in denaturing conditions as described in the technical manual using a Gibco/BRL sequencing apparatus Model SA 32. DNA was heated to 95ºC for 2 minutes, then chilled on ice prior to loading 3 µl of amplified product or 3 µl of allelic ladder onto the gel. Electrophoresis was performed at 40W in 0.5X TBE (Tris Borate Electrophoresis) Buffer for 1.5 hours. DNA was detected using the fluorescent stain SYBR Green II (1:10,000 dilution of stock-FMC) and visualized on the Molecular Dynamics Fluorimager at low resolution. Amplified product was analyzed by comparing the specimen amplified DNA migration with the amplified STR allelic ladder. All specimens were analyzed twice independently.

RESULTS AND DISCUSSION

Allelic frequencies of F13A01, F13B, and LPL are reported in Figures 1-3. Allelic frequencies for CSF1PO, TPOX, TH01, vWA, and FESFPS have been previously reported (5). Heterozygosity values, theoretical power of exclusion, observed power of exclusion, and median PI are reported in Table I. The observed combined power of exclusion values of Triplex I (CSF1PO, TPOX and TH01) Triplex II (F13A01, F13B, and LPL) , Duplex I (FESFPS, vWA) and D1S80 are summarized in Table 2.

The primary purpose of parentage testing is to exclude the falsely accused man. The ability of a genetic system or battery of genetic systems to exclude the falsely accused man is expressed as the power of exclusion. The American Association of Blood Banks Standards for Parentage Testing (11) has established an average power of exclusion of 95% to be the minimum standard for parentage testing. An average power of exclusion of one STR system is approximately 50%. Therefore, a battery of six STR systems or three STR systems and D1S80 meets this minimum standard set by the AABB.

In some cases using a six STR system test, paternity is not resolved with two exclusions or a paternity index of 100 or a specific probability of exclusion of 95%. This is due to the presence of common alleles. Therefore, a battery of eight STR loci are initially tested for typical paternity casework. By testing eight STR loci an average power of exclusion greater than 99.5 % can be obtained. The eight-system STR test results in resolving more than 99% of the casework with two exclusions or a paternity index of greater than 100. If additional testing is needed to resolve the case, then the amplified systems D1S80, CYAR04, or D19S253 (3,12) are utilized. For the rare cases involving single genetic inconsistencies between the alleged father and child, RFLP testing and/or HLA testing is utilized in conjunction with the STR analysis.

In conclusion, the analysis of STR loci to resolve paternity casework has been shown to be a reliable and useful technology. Enough STR loci are commercially available to resolve paternity casework by solely utilizing these loci and provide an average power of exclusion greater than 99.5% with paternity indices greater than one hundred.

ACKNOWLEDGMENTS

The authors thank Bruce Boeko, Jing Ming Liu and Helen Lawrence for technical/laboratory assistance, and Ruth Tutterow for editing assistance.

REFERENCES

  1. Edwards A., Civitello A., Hammond H.A. and Caskey C.T. (1991) DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am. J. Hum. Genet. 49:746-756.
  2. Edwards A., Civitello A., Hammond H.A., Caskey C.T. and Chakroborty R. (1992) Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12:241-253.
  3. Alford R.L. (1994) Rapid and efficient resolution of parentage by amplification of short tandem repeats. Am. J. Hum. Genet. 55:190-195.
  4. Hammond H.A., Jin L., Zhong Y., Caskey C.T. and Chakraborty R. (1994) Evaluation of 13 short tandem repeat loci for use in personal identification applications. Am. J. Hum. Genet. 55:175-189.
  5. Bever R. and Creacy S. (1994) Validation and utilization of commercially available STR multiplexes for parentage analysis. In: Proceedings from the Fifth International Symposium on Human Identification. Promega Corporation, 1995:61-68.
  6. Puers C., Hammond H.A., Caskey C.T., Lins A.M., Sprecher C.J., Brinkman B. and Schumm J.W. (1994) Allelic ladder characterization of the short tandem repeat polymorphism located in the 5' flanking region to the human coagulation factor XIII A subunit gene. Genomics 23:260.
  7. Nishimura D.Y. and Murray J.C. (1992) A tetranucleotide repeat for the F13B locus. Nucl. Acids Res. 20:1167.
  8. Zuliani G. and Hobbs H.H. (1990) Tetranucleotide repeat polymorphism in the LPL gene. Nucl. Acids Res. 18:4958.
  9. Miller S.A., Dykes D.D. and Polesky H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16:1215.
  10. Brink C.F., Jones K.D. and James T.W. (1979) Assay for nanogram quantities of DNA in cellular homogenates. Anal. Biochem. 92:497-500.
  11. Standards for Parentage Testing Laboratories. 2nd Edition. (1994). Arlington, VA:American Association of Blood Banks.
  12. Urquhart A., Oldroyd N.J., Kimpton C.P. and Gill P. (1995) Highly discriminating heptaplex short tandem repeat PCR system for forensic identification. BioTechniques 18:116-121.

Table 1. Power of Exclusion and Paternity Index: Consistency Checks

System

Database

Inclusionary Groups

 

h

Ah

Ao

Median Pl

Hispanic

       
CSF1PO

0.70

0.43

0.64

1.78

TPOX

0.67

0.38

0.46

2.02

THO1

0.74

0.49

0.40

2.28

F13A01

0.80

0.60

0.46

2.22

F13B

0.63

0.33

0.46

2.17

LPL

0.69

0.41

0.58

1.99

FESFPS

0.68

0.40

0.40

1.53

vWF

0.73

0.48

0.57

2.70

D1S80

0.81

0.62

0.66

2.36

Black

       
CSF1PO

0.81

0.62

0.59

2.16

TPOX

0.75

0.51

0.52

2.62

THO1

0.71

0.44

0.52

2.67

F13A01

0.78

0.56

0.56

2.56

F13B

0.73

0.48

0.70

2.60

LPL

0.69

0.41

0.63

2.70

FESFPS

0.70

0.43

0.46

1.94

vWF

0.78

0.56

0.61

1.87

D1S80

0.88

0.75

0.81

5.71

Caucasian

       
CSF1PO

0.75

0.51

0.44

1.78

TPOX

0.65

0.36

0.41

1.77

THO1

0.76

0.53

0.55

3.02

F13A01

0.76

0.53

0.49

2.02

F13B

0.75

0.51

0.48

1.89

LPL

0.77

0.54

0.46

2.43

FESFPS

0.69

0.41

0.44

1.97

vWF

0.83

0.66

0.62

1.98

D1S80

0.82

0.64

0.72

2.80

h = heterozygosity
Ah = Power of Exclusion = h2 (1-2hH2): h = heterozygosity; H = homozygosity1
Ao = Observed Power of Exclusion frm 100 exclusionary cases
Median Pl = Median Pl from 200 exclusionary cases
1 Brenner C. and Morris J. (1989) Paternity index calculations in single locus hypervariable DNA probes: validation and other studies. In: Proceedings from the International Symposium on Human Identification. Promega Corporation, 1990: 21-53.

Table 2. Varying Battery of Tests: Observed Power of Exclusion

Test

Black

Caucasian

Hispanic

CTT

92.00%

85.00%

86.00%

FFL

95.00%

85.00%

85.00%

D1S80+CTT

98.50%

95.50%

95.20%

FFL+D1S80

99.00%

95.80%

95.00%

FFL+CTT

99.60%

97.60%

97.90%

FFL+CTT+D1S80

99.90%

99.30%

99.20%

FFL+CTT+FV

99.92%

99.50%

99.50%

D1S80+FFL+CTT+FV

99.98%

99.91%

99.84%


Figure 1.

Figure 2.

Figure 3.


Go to proceedings home page